Accounting reportsPreviously
|
Name | APTEKA 36,6, OOO |
|---|
INN | 7017073419 |
|---|
KPP | 701701001 |
|---|
OGRN | 1037000128990 |
|---|
OKPO | 14408199 |
|---|
Address | 634050, Tomskaya Oblast', g. Tomsk, pr-kt Lenina, d. D.87 |
|---|
Phone | +7 (913) 802-34-16 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | 47.75 | Additional activity | Retailing of cosmetics and personal hygiene products in specialized stores |
Registration date | 04.06.2003 |
|---|
Registering department | Inspektsiya Ministerstva Rossiyskoy Federatsii po nalogam i sboram po goroduTomsku Tomskoy oblasti |
|---|
|
APTEKA 36,6, OOO (Tomsk Oblast; INN 7017073419) was registered on 4 Jun 2003. The company's authorized capital as of July 1, 2012 was 10000 rub. Type of ownership of APTEKA 36,6, OOO - Limited liability companies. Form of ownership of APTEKA 36,6, OOO - Private property. Principal activities of APTEKA 36,6, OOO: retailing drugs in specialized stores (pharmacies) (47.73), retailing products used for medical purposes, orthopedic goods in specialized stores (47.74), retailing of cosmetics and personal hygiene products in specialized stores (47.75). |
Economic indicators2023
Net profit (RAS) of APTEKA 36,6, OOO dropped in 2023 3.44 times to 1.48 million RUB from 5.10 million RUB over the same period in 2022, the company informed. Revenue increased in the accounting period by 19.99% to 495.46 million RUB from 412.93 million RUB over 2022. 2022
Net profit (RAS) of APTEKA 36,6, OOO dropped in 2022 4.53 times to 5.10 million RUB from 23.10 million RUB over the same period in 2021, the company informed. Revenue increased in the accounting period by 6.54% to 412.93 million RUB from 387.60 million RUB over 2021. 2021
Net profit (RAS) of APTEKA 36,6, OOO grew over 2021 by 20.34% to 23.10 million RUB from 19.20 million RUB over 2020, the company informed. Revenue decreased in the accounting period by 5.77% to 387.60 million RUB from 411.33 million RUB in 2020. 2020
Net profit (RAS) of APTEKA 36,6, OOO made up 19.20 million RUB over 2020 compared to net loss of 5.43 million RUB over 2019, the company informed. Revenue decreased in the accounting period by 0.74% to 411.33 million RUB from 414.39 million RUB in 2019. 2018
Net profit (RAS) of APTEKA 36,6, OOO dropped in 2018 by 31.26% to 6.53 million RUB from 9.50 million RUB over the same period in 2017, the company informed. Revenue increased in the accounting period by 3.91% to 408.00 million RUB from 392.66 million RUB over 2017; cost of goods sold grew by 4.54% to 395.73 million RUB from 378.53 million RUB; sales profit fell by 13.13% to 12.27 million RUB from 14.13 million RUB. 2017
Net profit (RAS) of APTEKA 36,6, OOO grew over 2017 14.66 times to 9.50 million RUB from 648.00 thousand RUB over 2016, the company informed. Revenue increased in the accounting period 1.53 times to 392.66 million RUB from 256.40 million RUB over 2016; cost of goods sold grew by 49.56% to 378.53 million RUB from 253.10 million RUB; sales profit went up 4.28 times to 14.13 million RUB from 3.30 million RUB. 2016
Net profit (RAS) of APTEKA 36,6, OOO dropped in 2016 by 37.75% to 648.00 thousand RUB from 1.04 million RUB over the same period in 2015, the company informed. Revenue increased in the accounting period 2.03 times to 256.40 million RUB from 126.56 million RUB over 2015; cost of goods sold grew 1.97 times to 253.10 million RUB from 128.69 million RUB; sales profit made up 3.30 million RUB compared to sales loss of 2.13 million RUB. 2014
Net profit (RAS) of Apteka 36,6, OOO dropped in 2014 37.50 times to 8.00 thousand RUB from 300.00 thousand RUB over the same period in 2013, the company informed. Revenue increased in the accounting period 2.03 times to 73.88 million RUB from 36.30 million RUB over 2013; cost of goods sold grew 2.05 times to 73.00 million RUB from 35.65 million RUB; sales profit went up by 34.25% to 878.00 thousand RUB from 654.00 thousand RUB. 2013
Net loss (RA) of Apteka 36,6, OOO made up 772.00 thousand RUB over 2013 compared to net profit of 3.29 million RUB over 2012, the company informed. Revenue increased in the accounting period by 15.20% to 36.30 million RUB from 31.51 million RUB over 2012; cost of goods sold grew by 11.07% to 27.71 million RUB from 24.95 million RUB; sales loss made up 418.00 thousand RUB compared to sales profit of 3.60 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|